339 related articles for article (PubMed ID: 16043867)
1. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
Nagai N; Oike Y; Noda K; Urano T; Kubota Y; Ozawa Y; Shinoda H; Koto T; Shinoda K; Inoue M; Tsubota K; Yamashiro K; Suda T; Ishida S
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2925-31. PubMed ID: 16043867
[TBL] [Abstract][Full Text] [Related]
2. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
[TBL] [Abstract][Full Text] [Related]
3. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
4. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation.
Kubota S; Kurihara T; Mochimaru H; Satofuka S; Noda K; Ozawa Y; Oike Y; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3512-9. PubMed ID: 19279313
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin.
Satofuka S; Ichihara A; Nagai N; Yamashiro K; Koto T; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Suzuki F; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2686-92. PubMed ID: 16723487
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
Kurihara T; Ozawa Y; Shinoda K; Nagai N; Inoue M; Oike Y; Tsubota K; Ishida S; Okano H
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5545-52. PubMed ID: 17122147
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats.
Suzuki J; Manola A; Murakami Y; Morizane Y; Takeuchi K; Kayama M; Miller JW; Sobrin L; Vavvas DG
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6565-71. PubMed ID: 21775660
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis.
Ishida S; Koto T; Nagai N; Oike Y
Jpn J Ophthalmol; 2010 Nov; 54(6):594-601. PubMed ID: 21191722
[TBL] [Abstract][Full Text] [Related]
11. Contribution of E-selectin to cellular infiltration during endotoxin-induced uveitis.
Suzuma I; Mandai M; Suzuma K; Ishida K; Tojo SJ; Honda Y
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1620-30. PubMed ID: 9699551
[TBL] [Abstract][Full Text] [Related]
12. A cholinergic agonist attenuates endotoxin-induced uveitis in rats.
Chi ZL; Hayasaka S; Zhang XY; Cui HS; Hayasaka Y
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2719-25. PubMed ID: 17525204
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13.
Marie O; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2275-82. PubMed ID: 10476793
[TBL] [Abstract][Full Text] [Related]
14. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
[TBL] [Abstract][Full Text] [Related]
15. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of glucosamine on endotoxin-induced uveitis in Lewis rats.
Chang YH; Horng CT; Chen YH; Chen PL; Chen CL; Liang CM; Chien MW; Chen JT
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5441-9. PubMed ID: 18719082
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats.
Miyazaki A; Kitaichi N; Ohgami K; Iwata D; Jin XH; Iwabuchi K; Morohashi T; Ohno S; Onoé K
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):747-57. PubMed ID: 18087711
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of antithrombin III against leukocyte rolling and infiltration during endotoxin-induced uveitis in rats.
Yamashiro K; Kiryu J; Tsujikawa A; Honjo M; Nonaka A; Miyamoto K; Honda Y; Tanihara H; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1553-60. PubMed ID: 11381060
[TBL] [Abstract][Full Text] [Related]
20. Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro.
Chen CL; Chen JT; Liang CM; Tai MC; Lu DW; Chen YH
PLoS One; 2017; 12(4):e0174971. PubMed ID: 28376126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
